Skip to main content
. Author manuscript; available in PMC: 2007 Jun 21.
Published in final edited form as: Lancet. 2005 Aug 13;366(9485):549–555. doi: 10.1016/S0140-6736(05)67098-5

Table 3.

Infected cells per billion (IUPB) resting CD4+ T cells

Patient IUPB on HAART IUPB on HAART Interval (months)
1 57 41 1
2 42 72 3
3 290 240 2
4 140 130 15
5 20 23 1

IUPB measurements from resting cell outgrowth assays on HAART prior to protocol therapy. Patient 5 was stably aviremic as per the entry criteria but did not receive T20 or VPA.